{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:55:57Z","timestamp":1757314557497},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004470","name":"Daewoong Pharmaceutical Company, Korea.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004470","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13063-017-2155-5","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T07:20:26Z","timestamp":1506064826000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"18","author":[{"name":"SAFE study investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghyun","family":"Ahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joongyub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Kee","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongwon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-il","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-Yi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Ji","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungsin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,22]]},"reference":[{"key":"2155_CR1","doi-asserted-by":"crossref","unstructured":"2011 Writing Group Members, 2005 Writing Group Members, ACCF\/AHA Task Force Members. 2011 ACCF\/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation. 2011;124:2020\u201345.","DOI":"10.1161\/CIR.0b013e31822e80c3"},{"issue":"Suppl S","key":"2155_CR2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","volume":"45","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5\u201367.","journal-title":"J Vasc Surg"},{"key":"2155_CR3","doi-asserted-by":"crossref","first-page":"e637S","DOI":"10.1378\/chest.11-2306","volume":"141","author":"PO Vandvik","year":"2012","unstructured":"Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e637S\u201368.","journal-title":"Chest"},{"key":"2155_CR4","doi-asserted-by":"crossref","first-page":"2s","DOI":"10.1016\/j.jvs.2014.12.009","volume":"61","author":"MS Conte","year":"2015","unstructured":"Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, et al. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg. 2015;61:2s\u201341.","journal-title":"J Vasc Surg"},{"key":"2155_CR5","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","volume":"22","author":"G Tepe","year":"2012","unstructured":"Tepe G, Bantleon R, Brechtel K, Schmehl J, Zeller T, Claussen CD, et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy--the MIRROR study: a randomised and double-blinded clinical trial. Eur Radiol. 2012;22:1998\u20132006.","journal-title":"Eur Radiol"},{"key":"2155_CR6","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","volume":"141","author":"GH Guyatt","year":"2012","unstructured":"Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:7S\u201347.","journal-title":"Chest"},{"key":"2155_CR7","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","volume":"301","author":"JS Berger","year":"2009","unstructured":"Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA. 2009;301:1909\u201319.","journal-title":"JAMA"},{"key":"2155_CR8","doi-asserted-by":"crossref","first-page":"27a","DOI":"10.1016\/j.amjcard.2008.11.020","volume":"103","author":"DJ Angiolillo","year":"2009","unstructured":"Angiolillo DJ. Variability in responsiveness to oral antiplatelet therapy. Am J Cardiol. 2009;103:27a\u201334.","journal-title":"Am J Cardiol"},{"key":"2155_CR9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1517\/13543784.13.7.865","volume":"13","author":"SA Doggrell","year":"2004","unstructured":"Doggrell SA. Sarpogrelate: cardiovascular and renal clinical potential. Expert Opin Investig Drugs. 2004;13:865\u201374.","journal-title":"Expert Opin Investig Drugs"},{"key":"2155_CR10","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4103\/0366-6999.158285","volume":"128","author":"YX Chen","year":"2015","unstructured":"Chen YX, Wang WD, Song XJ, Gu YQ, Tian HY, Hu HJ, et al. Prospective randomized study of sarpogrelate versus clopidogrel-based dual antiplatelet therapies in patients undergoing femoropopliteal arterial endovascular interventions: preliminary results. Chin Med J (Engl). 2015;128:1563\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"2155_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12272-014-0415-4","volume":"38","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Shin DH, Lim EA, Kim JS. Sustained-release formulation of sarpogrelate hydrochloride. Arch Pharm Res. 2015;38:35\u201341.","journal-title":"Arch Pharm Res"},{"key":"2155_CR12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/jcpt.12117","volume":"39","author":"TE Kim","year":"2014","unstructured":"Kim TE, Kim JR, Jung JA, Kim MJ, Lee SY, Ko JW, et al. Pharmacokinetics of a new once-daily controlled-release sarpogrelate hydrochloride compared with immediate-release formulation and the effect of food. J Clin Pharm Ther. 2014;39:192\u20135.","journal-title":"J Clin Pharm Ther"},{"key":"2155_CR13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.amjcard.2006.02.039","volume":"98","author":"DW Park","year":"2006","unstructured":"Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol. 2006;98:352\u20136.","journal-title":"Am J Cardiol"},{"key":"2155_CR14","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/eurheartj\/ehn232","volume":"29","author":"P Amarenco","year":"2008","unstructured":"Amarenco P, Steg PG. Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention. Eur Heart J. 2008;29:1605\u20137.","journal-title":"Eur Heart J"},{"key":"2155_CR15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","volume":"329","author":"GUSTO Investigators","year":"1993","unstructured":"Investigators GUSTO. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673\u201382.","journal-title":"N Engl J Med"},{"key":"2155_CR16","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","volume":"32","author":"M Tendera","year":"2011","unstructured":"Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clement D, Collet JP, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851\u2013906.","journal-title":"Eur Heart J"},{"key":"2155_CR17","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1161\/CIRCULATIONAHA.107.715433","volume":"116","author":"JH Rogers","year":"2007","unstructured":"Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation. 2007;116:2072\u201385.","journal-title":"Circulation"},{"key":"2155_CR18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329\u201339.","journal-title":"Lancet"},{"key":"2155_CR19","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","volume":"49","author":"DL Bhatt","year":"2007","unstructured":"Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, et al. Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol. 2007;49:1982\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"2155_CR20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","volume":"52","author":"JJ Belch","year":"2010","unstructured":"Belch JJ, Dormandy J, Biasi GM, Cairols M, Diehm C, Eikelboom B, et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg. 2010;52:825\u201333. 833.e1\u20132.","journal-title":"J Vasc Surg"},{"key":"2155_CR21","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1067\/mhj.2003.176","volume":"145","author":"M Fujita","year":"2003","unstructured":"Fujita M, Mizuno K, Ho M, Tsukahara R, Miyamoto A, Miki O, et al. Sarpogrelate treatment reduces restenosis after coronary stenting. Am Heart J. 2003;145:E16.","journal-title":"Am Heart J"},{"key":"2155_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-012-1490-9","volume":"373","author":"Y Su","year":"2013","unstructured":"Su Y, Mao N, Li M, Dong X, Lin FZ, Xu Y, et al. Sarpogrelate inhibits the expression of ICAM-1 and monocyte-endothelial adhesion induced by high glucose in human endothelial cells. Mol Cell Biochem. 2013;373:195\u20139.","journal-title":"Mol Cell Biochem"},{"key":"2155_CR23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.avsg.2016.01.032","volume":"35","author":"J Guo","year":"2016","unstructured":"Guo J, Gu Y, Guo L, Yu H, Qi L, Tong Z, et al. Effects of sarpogrelate combined with aspirin in patients undergoing carotid endarterectomy in China: a single-center retrospective study. Ann Vasc Surg. 2016;35:183\u20138.","journal-title":"Ann Vasc Surg"},{"key":"2155_CR24","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.clinthera.2013.09.004","volume":"35","author":"RJ Malloy","year":"2013","unstructured":"Malloy RJ, Kanaan AO, Silva MA, Donovan JL. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis. Clin Ther. 2013;35:1490\u2013500. e7.","journal-title":"Clin Ther"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2155-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:16:00Z","timestamp":1589775360000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2155-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2155"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2155-5","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2017,9,22]]},"article-number":"439"}}